215 related articles for article (PubMed ID: 6757263)
21. Interleukin-6 overproduction by cultured thymic epithelial cells from patients with myasthenia gravis is potentially involved in thymic hyperplasia.
Cohen-Kaminsky S; Devergne O; Delattre RM; Klingel-Schmitt I; Emilie D; Galanaud P; Berrih-Aknin S
Eur Cytokine Netw; 1993; 4(2):121-32. PubMed ID: 8318672
[TBL] [Abstract][Full Text] [Related]
22. Intrathymic Tfh/B Cells Interaction Leads to Ectopic GCs Formation and Anti-AChR Antibody Production: Central Role in Triggering MG Occurrence.
Zhang X; Liu S; Chang T; Xu J; Zhang C; Tian F; Sun Y; Song C; Yi W; Lin H; Li Z; Yang K
Mol Neurobiol; 2016 Jan; 53(1):120-131. PubMed ID: 25407929
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
[TBL] [Abstract][Full Text] [Related]
24. [B cell population and its autoimmune activity in the thymus of patients associated with myasthenia gravis].
Yoshitake T; Takahama T; Kanai F; Ohnishi K; Suzuki T; Kametani Y; Itoyama S; Sugawara I; Matsunaga A
Kyobu Geka; 1993 Dec; 46(13):1083-7; discussion 1087-9. PubMed ID: 8258907
[TBL] [Abstract][Full Text] [Related]
25. Thymic lymphocytes bear a surface antigen which cross-reacts with acetylcholine receptor.
Fuchs S; Schmidt-Hopfeld I; Tridente G; Tarrab-Hazdai R
Nature; 1980 Sep; 287(5778):162-4. PubMed ID: 7001247
[TBL] [Abstract][Full Text] [Related]
26. Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis.
Poëa-Guyon S; Christadoss P; Le Panse R; Guyon T; De Baets M; Wakkach A; Bidault J; Tzartos S; Berrih-Aknin S
J Immunol; 2005 May; 174(10):5941-9. PubMed ID: 15879086
[TBL] [Abstract][Full Text] [Related]
27. A histologic reappraisal of the thymus in myasthenia gravis. A correlative study of thymic pathology and response to thymectomy.
Alpert LI; Papatestas A; Kark A; Osserman RS; Osserman K
Arch Pathol; 1971 Jan; 91(1):55-61. PubMed ID: 4922629
[No Abstract] [Full Text] [Related]
28. Thymic involvement in myasthenia gravis. Study by immunofluorescent and immunoperoxidase staining.
Pizzighella S; Riviera AP; Tridente G
J Neuroimmunol; 1983 Apr; 4(2):117-27. PubMed ID: 6339556
[TBL] [Abstract][Full Text] [Related]
29. Greatly increased autoantibody production in myasthenia gravis by thymocyte suspensions prepared with proteolytic enzymes.
Willcox HN; Newsom-Davis J; Calder LR
Clin Exp Immunol; 1983 Nov; 54(2):378-86. PubMed ID: 6317238
[TBL] [Abstract][Full Text] [Related]
30. Antibodies to thymic epithelial cells in myasthenia gravis.
Safar D; Aimé C; Cohen-Kaminsky S; Berrih-Aknin S
J Neuroimmunol; 1991 Dec; 35(1-3):101-10. PubMed ID: 1720131
[TBL] [Abstract][Full Text] [Related]
31. T-cell antigenic sites involved in myasthenia gravis: correlations with antibody titre and disease severity.
Berrih-Aknin S; Cohen-Kaminsky S; Lepage V; Neumann D; Bach JF; Fuchs S
J Autoimmun; 1991 Feb; 4(1):137-53. PubMed ID: 2031657
[TBL] [Abstract][Full Text] [Related]
32. Macrophage subpopulations in the thymic hyperplasia of patients with myasthenia gravis.
Zhang J; Cohen-Kaminsky S; Berrih-Aknin S
Hum Antibodies Hybridomas; 1995; 6(4):153-60. PubMed ID: 8688498
[TBL] [Abstract][Full Text] [Related]
33. Myasthenia gravis.
Marx A; Schultz A; Wilisch A; Nenninger R; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1996; 80():116-26. PubMed ID: 9020569
[TBL] [Abstract][Full Text] [Related]
34. Antibody to acetylcholine receptor in myasthenia gravis: production by lymphocytes from thymus or thymoma.
Fujii Y; Monden Y; Nakahara K; Hashimoto J; Kawashima Y
Neurology; 1984 Sep; 34(9):1182-6. PubMed ID: 6611521
[TBL] [Abstract][Full Text] [Related]
35. Intrathymic lymphoid cell differentiation in myasthenia gravis: an immunophenotypic study.
Ferrio MF; Durelli L; Massazza U; Cavallo R; Poccardi G; Maggi G; Casadio C; Di Summa M; Bergamini L
Ital J Neurol Sci; 1991 Dec; 12(6):569-73. PubMed ID: 1783535
[TBL] [Abstract][Full Text] [Related]
36. Central role of interferon-beta in thymic events leading to myasthenia gravis.
Cufi P; Dragin N; Ruhlmann N; Weiss JM; Fadel E; Serraf A; Berrih-Aknin S; Le Panse R
J Autoimmun; 2014 Aug; 52():44-52. PubMed ID: 24393484
[TBL] [Abstract][Full Text] [Related]
37. Role of miRNAs in Normal and Myasthenia Gravis Thymus.
Cron MA; Guillochon É; Kusner L; Le Panse R
Front Immunol; 2020; 11():1074. PubMed ID: 32587589
[TBL] [Abstract][Full Text] [Related]
38. Immunohistological patterns of non-neoplastic changes in the thymus in Myasthenia gravis.
Kirchner T; Schalke B; Melms A; von Kügelgen T; Müller-Hermelink HK
Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(3):237-57. PubMed ID: 2879380
[TBL] [Abstract][Full Text] [Related]
39. The thymus in autoimmune Myasthenia Gravis: Paradigm for a tertiary lymphoid organ.
Weiss JM; Cufi P; Le Panse R; Berrih-Aknin S
Rev Neurol (Paris); 2013; 169(8-9):640-9. PubMed ID: 24008049
[TBL] [Abstract][Full Text] [Related]
40. The immunohistology of the thymus in myasthenia gravis.
Kornstein MJ; Brooks JJ; Anderson AO; Levinson AI; Lisak RP; Zweiman B
Am J Pathol; 1984 Nov; 117(2):184-94. PubMed ID: 6208785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
